Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 4,209,000 | 4,120,000 | 3,856,000 | 3,725,000 | 3,527,000 |
| Cost of Goods | 1,312,000 | 1,270,000 | 1,209,000 | 1,146,000 | 1,101,000 |
| Gross Profit | 2,897,000 | 2,850,000 | 2,648,000 | 2,579,000 | 2,426,000 |
| Operating Expenses | 2,164,000 | 2,330,000 | 1,974,000 | 1,993,000 | 1,734,000 |
| Operating Income | 733,000 | 520,000 | 675,000 | 584,000 | 693,000 |
| Interest Expense | 79,000 | 77,000 | 69,000 | 64,000 | 66,000 |
| Other Income | 15,000 | -23,000 | 2,000 | -15,000 | -17,000 |
| Pre-tax Income | 669,000 | 420,000 | 608,000 | 505,000 | 610,000 |
| Income Tax | 200,000 | 98,000 | 115,000 | 1,000 | 105,000 |
| Net Income Continuous | 469,000 | 322,000 | 493,000 | 504,000 | 505,000 |
| Minority Interests | N/A | -2,000 | -1,000 | N/A | N/A |
| Net Income | $468,000 | $324,000 | $494,000 | $503,000 | $504,000 |
| EPS Basic Total Ops | 0.32 | 0.22 | 0.34 | 0.35 | 0.34 |
| EPS Basic Continuous Ops | 0.32 | 0.22 | 0.34 | 0.35 | 0.34 |
| EPS Diluted Total Ops | 0.32 | 0.22 | 0.33 | 0.34 | 0.34 |
| EPS Diluted Continuous Ops | 0.32 | 0.22 | 0.33 | 0.34 | 0.34 |
| EPS Diluted Before Non-Recurring Items | 0.63 | 0.62 | 0.56 | 0.55 | 0.50 |
| EBITDA(a) | $1,039,000 | $1,107,000 | $977,000 | $899,000 | $993,000 |